Particularly NAB is a buy-back, like a thing will artificially be having a higher price for a while just off the back of that. In a higher interest rate environment there could well be better margins coming through for them too. I assume they are waiting for the next set of reporting results to suck and cash in lets hope
- Forums
- ASX - By Stock
- Ann: Investment Update and NTA December 2022
CDO
cadence opportunities fund limited.
Add to My Watchlist
0.59%
!
$1.68

Particularly NAB is a buy-back, like a thing will artificially...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.68 |
Change
-0.010(0.59%) |
Mkt cap ! $26.87M |
Open | High | Low | Value | Volume |
$1.69 | $1.69 | $1.67 | $6.215K | 3.705K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 8564 | $1.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.70 | 11764 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3191 | 1.680 |
1 | 375 | 1.660 |
1 | 3067 | 1.630 |
2 | 19000 | 1.610 |
2 | 2500 | 1.600 |
Price($) | Vol. | No. |
---|---|---|
1.700 | 11764 | 1 |
1.720 | 6608 | 2 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 15.58pm 18/06/2025 (20 minute delay) ? |
Featured News
CDO (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online